Clinical Trials Directory

Trials / Completed

CompletedNCT00528853

Correlation of Lung Biopsy, BAL, and High Resolution CT Scan in Lung Transplantation

Correlation of Lung Biopsy, BAL, and High Resolution CT Scan in Lung Transplantation. Can We Help Diagnose Acute Rejection and Better Predict Bronchiolitis Obliterans?

Status
Completed
Phase
Study type
Observational
Enrollment
10 (actual)
Sponsor
University of Chicago · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

A major source of graft failure and dysfunction in lung transplantation is known to be bronchiolitis obliterans (BO)and its clinical correlate called bronchiolitis obliterans syndrome(BOS). In fact, BOS is the leading cause of death in lung recipients beyond one year post transplant. Currently, our ability to assess lung injury after transplant is less than ideal. The purpose of this study is to use new computerized tomography(CT) technology, specifically , 64 bit acquisition, to detect and predict the onset of lung injuries, with the hope of finding better therapies that currently exist.

Detailed description

Total enrollment : 10 Lung transplant patients will undergo CT Scans before scheduled bronchoscopies which are routinely performed at 1, 3, 6, 9, and 12 months post transplant. Imaging will be done with the newest generation scanner, with intent to analyze all pertinent areas of the lung for pathology, but especially the bronchial anastomoses, the lung parenchyma with focus on gas exchanging lobules of the lung, and any suspected abnormalities from physical exam, laboratory tests, or prior chest xray. CT imaging will precede bronchoscopy and biopsy so that CT interpretation will be unencumbered by changes due to the bronchoscopic procedure.

Conditions

Timeline

Start date
2007-08-01
Primary completion
2009-12-01
Completion
2009-12-01
First posted
2007-09-12
Last updated
2016-08-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00528853. Inclusion in this directory is not an endorsement.